アジア太平洋の全ゲノムおよびエクソームシーケンシング市場：エンドユーザー別、国別 - 分析と予測（2024年～2033年）

アジア太平洋の全ゲノムおよびエクソームシーケンシングの市場規模は、2024年の4億2,590万米ドルから2033年には17億8,480万米ドルに達し、予測期間の2024年～2033年のCAGRは15.13%になると予測されています。

WGSはゲノム全体を解析するのに対し、WESは疾患に関連するバリアントの大部分を含むタンパク質コード領域に集中します。コストの低下と用途の拡大に伴い、これらの技術はますます普及しています。

アジア太平洋における全ゲノムおよびエクソームシーケンシング市場は、ゲノミクスの進歩、遺伝性疾患の有病率の上昇、精密医療への投資の増加により急速に拡大しています。臨床診断、オーダーメイド治療、生物医学研究はすべて、人のDNAを徹底的に調べる全ゲノムシーケンス（WGS）と、タンパク質をコードする領域に集中する全エクソームシーケンシング（WES）に依存しています。

政府の強力なイニシアチブ、バイオテクノロジー分野の成長、ヘルスケアプロバイダーと研究機関のパートナーシップの拡大により、中国、日本、韓国、インドなどの国々がこの市場をリードしています。シーケンシング技術のコスト低下、ビッグデータ解析や人工知能（AI）の利用により、市場は拡大しています。

生殖医療、薬理ゲノミクス、腫瘍学、希少疾患診断が重要な応用分野です。市場の需要は、消費者直接（DTC）検査サービスの台頭や遺伝子検査に対する意識の高まりにも影響されています。しかし、データのプライバシー、複雑な規制、道徳的なジレンマといった問題はまだ残っています。

これらを考慮すると、アジア太平洋の全ゲノムおよびエクソームシーケンシング市場は、テクノロジーの進歩、ヘルスケアコストの上昇、正確でデータ駆動型の医療ソリューションに対する需要の高まりにより、大きく成長すると予想されます。

当レポートでは、アジア太平洋の全ゲノムおよびエクソームシーケンシング市場について調査し、市場の概要とともに、エンドユーザー別、国別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

エグゼクティブサマリー

第1章 業界の展望

• 市場動向
• COVID-19による市場への影響
• 規制の枠組み
• サプライチェーン分析
• 市場力学の概要

第2章 地域

• 地域別概要
• アジア太平洋

第3章 市場-競合ベンチマーキングと企業プロファイル

• 主要戦略と開発
• 企業プロファイル
  • BGI Group (Beijing Genomics Institute (BGI))
  • Novogene Corporation

第4章 調査手法

List of Figures

• Figure 1: Asia-Pacific Whole Genome and Exome Sequencing Market (by End User), $Million, 2023, 2026, and 2033
• Figure 2: Key Events to Keep Track of within the Whole Genome and Exome Sequencing Market
• Figure 3: Value and Supply Chain Analysis, Whole Genome and Exome Sequencing Market
• Figure 4: Analysis of Market Navigating Factors, 2023-2033
• Figure 5: Key Clinical Applications of Whole Genome and Whole Exome Sequencing
• Figure 6: Number of Research Papers Mentioning Personalized Medicine in PubMed, 2010-2023
• Figure 7: Decreasing Genome Sequencing Costs
• Figure 8: Map of a Few Recent and Ongoing Government-Funded National Genomic-Medicine Initiatives
• Figure 9: Examples of Security Breaches in Whole Genome and Exome Sequencing
• Figure 10: China Whole Genome and Exome Sequencing Market, $Million, 2023-2033
• Figure 11: India Whole Genome and Exome Sequencing Market, $Million, 2023-2033
• Figure 12: Australia Whole Genome and Exome Sequencing Market, $Million, 2023-2033
• Figure 13: Japan Whole Genome and Exome Sequencing Market, $Million, 2023-2033
• Figure 14: Singapore Whole Genome and Exome Sequencing Market, $Million, 2023-2033
• Figure 15: Rest-of-Asia-Pacific Whole Genome and Exome Sequencing Market, $Million, 2023-2033
• Figure 16: Strategic Initiatives, January 2021-April 2024
• Figure 17: Share of Strategic Initiatives, January 2021-April 2024
• Figure 18: Data Triangulation
• Figure 19: Top-Down and Bottom-Up Approach
• Figure 20: Assumptions and Limitations

List of Tables

• Table 1: Market Snapshot
• Table 2: Opportunities across Regions
• Table 3: Recent Technological Innovations
• Table 4: Few Major Inorganic Growth Activities in the Whole Genome and Exome Sequencing Market
• Table 5: Whole Genome and Exome Sequencing Market (by Region), $Million, 2023-2033
• Table 6: Asia-Pacific Whole Genome and Exome Sequencing Market (by End User), $Million, 2023-2033

Introduction to Asia-Pacific Whole Genome and Exome Sequencing Market

The Asia-Pacific whole genome and exome sequencing market is projected to reach $1,784.8 million by 2033 from $425.9 million in 2024, growing at a CAGR of 15.13% during the forecast period 2024-2033. WGS analyses the entire genome, whereas WES concentrates on protein-coding regions that contain the majority of disease-related variants. As costs come down and applications increase, these technologies are becoming more and more popular.

Market Introduction

The market for whole genome and exome sequencing in Asia-Pacific (APAC) is expanding quickly due to advances in genomics, an increase in the prevalence of genetic disorders, and growing investments in precision medicine. Clinical diagnostics, customised treatments, and biomedical research all depend on whole genome sequencing (WGS), which offers a thorough examination of a person's DNA, and whole exome sequencing (WES), which concentrates on protein-coding regions.

With robust government initiatives, growing biotechnology sectors, and growing partnerships between healthcare providers and research institutions, nations like China, Japan, South Korea, and India are leading this market. The market is expanding due to the declining cost of sequencing technologies, as well as the use of big data analytics and artificial intelligence (AI).

Reproductive health, pharmacogenomics, oncology, and rare disease diagnosis are important applications. Demand in the market is also being influenced by the rise of direct-to-consumer (DTC) testing services and increased awareness of genetic testing. But there are still issues like data privacy, complicated regulations, and moral dilemmas.

All things considered, the APAC whole genome and exome sequencing market is expected to grow significantly due to advancements in technology, rising healthcare costs, and the growing demand for accurate, data-driven medical solutions.

Market Segmentation:

Segmentation 1: by End User

• Pharmaceutical and Biotechnology Companies
• Diagnostic Laboratories
• Hospitals and Clinics
• Research and Academic Institutes
• Others

Segmentation 2: by Country

• Japan
• India
• China
• Singapore
• Australia
• Rest-of-Asia-Pacific

How can this report add value to an organization

Product/Innovation Strategy: The report offers in-depth insights into the latest technological advancements and emerging applications in genome and exome sequencing, enabling organizations to drive innovation and develop cutting-edge products tailored to market needs.

Growth/Marketing Strategy: By providing comprehensive market analysis and identifying key growth opportunities, the report equips organizations with the knowledge to craft targeted marketing strategies and expand their market presence effectively.

Competitive Strategy: The report includes a thorough competitive landscape analysis, helping organizations understand their competitors' strengths and weaknesses and allowing them to strategize effectively to gain a competitive edge in the market.

Key Market Players and Competition Synopsis

Profiled companies have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

• BGI Group
• Novogene Corporation

Table of Contents

Executive Summary

Scope and Definition

1 Industry Outlook

• 1.1 Market Trends
  • 1.1.1 Technological Innovations in the Sequencing Technology
  • 1.1.2 Numerous Inorganic Growth Activities in the Market
• 1.2 COVID-19 Impact on Market
• 1.3 Regulatory Framework
  • 1.3.1 Legal Requirements and Framework in Japan
• 1.4 Supply Chain Analysis
• 1.5 Market Dynamics Overview
  • 1.5.1 Market Drivers
    • 1.5.1.1 Growing Applications of Whole Genome and Exome Sequencing in Clinical Diagnostics
    • 1.5.1.2 Rising Demand for Personalized Medicine Influencing the Demand for Whole Genome and Exome Sequencing
    • 1.5.1.3 Lowering Costs and Increasing Accessibility of Genome Sequencing
    • 1.5.1.4 Ongoing Whole Genome Sequencing Government Initiatives around the World
  • 1.5.2 Market Restraints
    • 1.5.2.1 Privacy and Ethical Concerns due to Increased Risk of Security Breaches
  • 1.5.3 Market Opportunities
    • 1.5.3.1 Increasing Usage of Sequencing Technology in Emerging Markets

2 Region

• 2.1 Regional Summary
• 2.2 Asia-Pacific
  • 2.2.1 Regional Overview
  • 2.2.2 Driving Factors for Market Growth
  • 2.2.3 Factors Challenging the Market
    • 2.2.3.1 By End User
  • 2.2.4 China
  • 2.2.5 India
  • 2.2.6 Australia
  • 2.2.7 Japan
  • 2.2.8 Singapore
  • 2.2.9 Rest-of-Asia-Pacific

3 Markets - Competitive Benchmarking & Company Profiles

• 3.1 Key Strategies and Development
• 3.2 Company Profiles
  • 3.2.1 BGI Group (Beijing Genomics Institute (BGI))
    • 3.2.1.1 Overview
    • 3.2.1.2 Top Products
    • 3.2.1.3 Top Competitors
    • 3.2.1.4 Key Personnel
    • 3.2.1.5 Analyst View
  • 3.2.2 Novogene Corporation
    • 3.2.2.1 Overview
    • 3.2.2.2 Top Products/Product Portfolio
    • 3.2.2.3 Top Competitors
    • 3.2.2.4 Key Personnel
    • 3.2.2.5 Analyst View

4 Research Methodology

• 4.1 Data Sources
  • 4.1.1 Primary Data Sources
  • 4.1.2 Secondary Data Sources
  • 4.1.3 Data Triangulation
• 4.2 Market Estimation and Forecast